Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
News - Page 18 of 29
-
Supporting more people to challenge injustices: A day in the life of a treatment activist
What got you interested in treatment activism to start with? Someone in my family was struggling to access life-saving medicines....
-
Apply to join ITPC’s Patent Opposition Academy
Applications are open to the Patent Oppositions Academy (the Academy) 2019-2021 for applicants living in El Salvador, Guatemala, Honduras and...
-
Brazilian Health Minister’s speech on compulsory licenses exposes a disconnect with the world
Adapted from a story first published by GTPI. Compulsory licensing is a vital public policy tool to combat the high...
-
World Hepatitis Day 2019: 1.4 million lives lost since last year
Today, 28 July, is World Hepatitis Day 2019. Since the day was marked in 2018, another 1.4 million people have...
-
ITPC’s IAS 2019 highlights!
The International AIDS Society (IAS) conferences are always bursting with events, announcements and debates, and the 10th International Conference on...
-
IAS 2019: Activists demand universal access to medicines
Today in Mexico City, dozens of treatment activists at the International AIDS Society (IAS) conference took over several drug company...
-
AIDS activists demand access to important cryptococcal meningitis drug
At the 10th International HIV Conference on Science (IAS 2019) taking place in Mexico City, AIDS activists protested Gilead’s inaction...
-
The right to health is compulsory: Time for action on dolutegravir – now!
Why Algeria, Azerbaijan, Belarus, Brazil, Bulgaria, China, Colombia, Kazakhstan, Mexico, Romania, Russia, and Turkey must issue compulsory licences on dolutegravir...
-
Still an avoidable tragedy: Brazil’s view on the EU-Mercosur free-trade agreement
The signing of the Free Trade Agreement (FTA) between Mercosur and the European Union on 28 June 2019, means that...
-
Old wine in new bottles: Keep TRIPS-plus provisions out of the RCEP FTA!
Intellectual property barriers, which would hinder access to affordable medicines, have supposedly been removed from the draft RCEP free-trade agreement...
-
Ukraine hosts regional congress on intellectual property and access to medicines
Over 100 people from more than 10 countries met in Kiev for the ‘Congress on Intellectual Property (IP) and Access...
-
Drug users under the microscope: Temo’s experience in Georgia
“I was in prison when I was diagnosed with Hepatitis B,” says Temo, 33. “I was just left with the...